Publications
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science
PDF
Authors: 

J. Compston, D. M. Reid, J. Boisdron, M.-L. Brandi, N. Burlet, D. Cahall, P. D. Delmas, W. Dere, J.-P. Devogelaer, L. A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van Staa, J.-Y. Reginster

Date: 
July 5 2008
DOI: 
10.1007/s00198-008-0670-7
Affiliations:

J. Compston, D. M. Reid, J. Boisdron, M.-L. Brandi, N. Burlet, D. Cahall, P. D. Delmas, W. Dere, J.-P. Devogelaer, L. A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van Staa, J.-Y. Reginster

J. Compston
Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK

D. M. Reid
University of Aberdeen Medical School, Foresterhill, Aberdeen AB25 2ZD, UK

J. Boisdron 
Hoffman-La Roche Ltd, Basle, Switzerland

M.-L. Brandi
Metabolic Bone Unit, Laboratory of Molecular Genetics, Department of Internal Medicine, University of Florence, Florence, Italy

N. Burlet
International Osteoporosis Foundation, Nyon, Switzerland

D. Cahall 
Sanofi-Aventis, Cincinnati, USA

P. D. Delmas
Department of Medicine, University of Lyon and INSERM Research Unit 831, Lyon, France

W. Dere
Amgen, Thousand Oaks, CA, USA

J.-P. Devogelaer
The Arthritis Unit, Université Catholique de Louvain, Brussels, Belgium

L. A. Fitzpatrick
Medicines Disease Center, GlaxoSmithKline, King of Prussia, PA, USA

B. Flamion
Laboratory of Physiology and Pharmacology, University of Namur,
Namur, Belgium

N. Goel
Clinical Development, UCB Inc., Smyrna, GA, USA

S. Korte Novartis Pharma, AG, Switzerland

A. Laslop
AGES PharmMed, Vienna, Austria

B. Mitlak
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

S. Ormarsdottir
Icelandic Medicines Control Agency, Seltjarnarnes, Iceland

J. Ringe
West German Osteoporosis Center (WOZ) and Med. Clinic 4 at Klinikum Leverkusen, Univerity of Cologne,
Cologne, Germany

R. Rizzoli
Division of Bone Diseases,
WHO Collaborating Centre for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics,
Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

Y. Tsouderos
Institut de Recherches Internationales Servier, Courbevoie, France

T. Van Staa
General Practice Research Database,
Medicines and Healthcare Products Regulatory Agency, London, UK

J.-Y. Reginster
Department of Public Health Sciences, University of Liège, Liège, Belgium, Chairman GREES,
Liège, Belgium


JOURNAL

Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.

Discover the official journal of ESCEO on Springer.com and read the journal contents on Springerlink.com.
You can get the table of contents of every new issue published in Aging Clinical and Experimental Research. Sign up for the ToC Alert for this journal with your e-mail address. It’s easy and it’s free.